HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laëtitia Prival Selected Research

Riluzole

1/2018Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laëtitia Prival Research Topics

Disease

2Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 01/2018
2Neoplasms (Cancer)
12/2021 - 01/2018
1Hypersensitivity (Allergy)
12/2021
1Peripheral Nervous System Diseases (PNS Diseases)
12/2021
1Channelopathies
12/2021
1Polyps
01/2018
1Cold Hypersensitivity
01/2018

Drug/Important Bio-Agent (IBA)

2Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2021 - 01/2018
1Ion Channels (Ion Channel)IBA
12/2021
1Histone Deacetylase InhibitorsIBA
12/2021
1entinostat (MS 275)IBA
12/2021
1Histone Deacetylases (Histone Deacetylase)IBA
12/2021
1Potassium Channels (Potassium Channel)IBA
12/2021
1potassium channel protein TREK-1IBA
01/2018
1RiluzoleFDA LinkGeneric
01/2018